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Introduction: An embryonic paratesticular rhabdomyosarcoma is a very rare mesenchymal tumor. It is an
intrascrotal tumor that is localized in paratesticular structures such as the epididymis or spermatic cord.
Rhabdomyosarcoma is most often observed in children and adolescents, presenting as a painless scrotal mass.
Case presentation: Our patient was an 18-year-old Moroccan man who presented with a painless left scrotal mass
that had evolved over four months. An inguinal orchiectomy was performed. A histological examination of the
excised tissue revealed an embryonic rhabdomyosarcoma.
Our patient had three sessions of chemotherapy with vincristine, actinomycin C and cyclophosphamide. Each
chemotherapy session was conducted over five days, with a cycle of 21 days. Our patient was assessed two months
after the last chemotherapy session and demonstrated good clinical improvement.
Conclusion: Paratesticular rhabdomyosarcoma is a rare aggressive tumor manifesting in children and very young
adults. Localized forms have a good prognosis whereas metastatic tumors show very poor results. A well-defined
treatment based on surgery and chemotherapy yields good results.Introduction
An embryonic paratesticular rhabdomyosarcoma is a
very rare mesenchymal tumor. It is an intrascrotal tumor
that is localized in paratesticular structures such as the
epididymis or spermatic cord. Rhabdomyosarcoma is
most often observed in children and adolescents where
it is usually presents as a painless scrotal mass [1].
We report the case of an 18-year-old man who
presented with a large mass that had developed over
four months. An investigation into tumoral markers was
negative. The surgical intervention consisted of left or-
chiectomy. A histological examination of the surgical
specimen confirmed embryonic paratesticular rhabdo-
myosarcoma. Adjuvant chemotherapy was initiated.Case presentation
Our patient was an 18-year-old Moroccan man who
presented with a painless left scrotal mass that had
evolved over four months. A clinical examination revealed* Correspondence: drbouchikhi@gmail.com
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reproduction in any medium, provided the ora hard testicular mass in his left side with a diameter of
10cm; the mass was renitent, static and suspicious.
Clinical examinations of his lymph nodes and abdomen
were normal. An ultrasound revealed an expansive process
characterized by intrascrotal heterogeneous tissue density.
A computed tomography (CT) scan of his thorax, abdo-
men and pelvis showed a left heterogeneous testicular
tumoral process with high adherence measuring 7cm to
8cm. However, neither pelvic nor lombo-aortic lymph-
adenopathy was revealed. The thoraco-abdomino-pelvic
CT scan did not show any metastases.
Our patient’s levels of tumoral markers alpha-
fetoprotein, beta-human chorionic gonadotropin and
angiotensin-converting enzyme were normal. An in-
guinal orchiectomy was performed. A histological
examination of the surgical specimen demonstrated
tumoral proliferation with unorganized architecture in
sheets of pleomorphic clear tumoral cytoplasmic cells and
eosinophils with atypical nuclei; eccentric aspects with
strong nucleoli and multi-nucleoli with rhabdomyoblastic
aspects were observed. This confirmed the diagnosis of an
embryonic rhabdomyosarcoma.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Histological aspects of embryonic paratesticular
rhabdomyosarcoma, ×50 magnification. (Hematoxylin and
eosin stain).
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expression in less than half of the tumoral cells (Figures 1
and 2).
Three chemotherapy sessions of vincristine 1.5 mg/
m2, actinomycin C 1.5mg/m2 and cyclophosphamide
500 mg/m2 were performed. Each chemotherapy session
was conducted over five days, with a cycle of 21 days. Our
patient was assessed two months after his last chemother-
apy session and demonstrated good clinical improvement.
Discussion
Rhabdomyosarcoma usually occur in the extremities. A
paratesticular localization is rare; the tumor develops
from mesenchymal tissues of the spermatic cord, and
epididymis.
There are two frequency peaks found for the develop-
ment of rhabdomyosarcoma, the first at the age of 4
years and the second at the age of 18 years, as in our
case. There is no predilection for race [2].
The consensus is that this tumor derives from mesen-
chymal elements of the testis envelope, epididymis and
spermatic cord. The tumor manifests as a hard painless
inguinoscrotal swelling, the size and duration of devel-
opment are varied and it rarely invades the scrotal skin.
The mass might evolve within the external inguinal ring
away from the scrotal contents [2,3]. A clinical examin-
ation should be complemented by an examination of the
lymph nodes and a general examination to investigate
metastases. Differential diagnoses include testicular tor-
sion, orchiepididymitis, scrotal abscess and, rarely, tes-
ticular tuberculosis.
A testicular ultrasound is routinely performed for a
scrotal mass. This imaging modality shows a mass with
heterogeneous echogenicity and inguinoscrotal exten-
sion in 80% of cases [4]. This allows the nature of the
intrascrotal tissue mass to be determined and specifies
the exact topography. Ultrasound is used to establishFigure 1 Histological aspects of embryonic paratesticular
rhabdomyosarcoma ×20 magnification. (Hematoxylin and
eosin stain).the differential diagnosis and eliminate diagnoses of
simple cyst and varicocele.
A thoraco-abdomino-pelvic CT scan allows for any
deep invasion of the lymph nodes to be investigated, es-
pecially lombo-aortic and pelvic metastases as well as
possible metastases to the liver or lung. Most authors
prefer the use of thoraco-abdomino-pelvic CT compared
to ultrasound for lymphomas.
Magnetic resonance imaging is an efficient imaging
modality when using surface coils. The tumor appears
homogeneous in T1-weighted images and heterogeneous
in T2-weighted images with signal intensity similar to that
in a normal testis. The low signal intensity of the tunica
albuginea in T2-wieghted images allows the visualization
of a clear separation of the mass from the testis [1,5,6].
In rhabdomyosarcoma, tumoral markers including
alpha-fetoprotein, beta-human chorionic gonadotropin
and carcinoembryonic antigen are usually normal. This
was the case with our patient.
A malignant tumor might be suspected in masses sit-
ting in the distal cord with a hard and irregular form ad-
hering to surrounding structures; a rapid increase in
tumor volume might be noted. But the diagnosis is mainly
made using histology. The macroscopic features include
a lobed tumor surrounded by whitish pseudocapsules,
hemorrhagic array are sometimes revealed [7].
There are four histological types of rhabdomyosar-
coma: pleomorphic, alveolar, botryoidal, and embryonal,
such as found in our patient. The characteristic cell is
rhabdomyoblast, which is not necessary for the diagno-
sis. Whenever rhabdomyoblasts are not present, immu-
nohistochemical investigations are conducted using a
panel of antibodies including myosin and desmin [6,8,9].
Rhabdomyosarcoma may be included in the differen-
tial diagnosis for other paratesticular sarcomas such
leiomyosarcoma, liposarcoma and fibrosarcoma. How-
ever, these pathologies occur more often in adults.
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The final diagnosis can be established by histological
study after surgical excision of the tumoral mass [6,7].
Radical orchidectomy by the inguinal route with first
cord ligation remains the essential act for histological
diagnosis and constitutes the first step of treatment re-
gardless of the stage of the disease. Hemiscrotectomy as-
sociating inguinal treatment is indicated first in scrotal
cases whenever local invasion or presence of lymph are
clinically evidenced [6,7]. An inguinal lymphadenectomy
should not be performed without first obtaining im-
aging, including a CT scan or lymphography.
Chemotherapy should be routinely administered since
rhabdomyosarcoma is chemosensitive. This therapeutic
approach consists of administrating actinomycin D, vin-
cristine and cyclophosphamide [5-7,10]. Radiotherapy is
a complementary treatment of chemotherapy and sur-
gery to eliminate residual foci and retroperitoneal lymph
nodes.
Our patient benefited from an inguinal orchiectomy.
Three sessions of chemotherapy were performed, resulting
in no signs of metastasis or residual foci.
Conclusion
Paratesticular rhabdomyosarcoma is a rare aggressive
tumor manifesting in children and very young adults.
Localized forms have a good prognosis whereas metastatic
tumors show very poor results. A well-defined treatment
based on surgery and chemotherapy yields good results.
Radiotherapy is indicated in cases of residual foci and
retroperitoneal lymphnodes. Strict follow-up has to be in-
stituted for all patients.
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